Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Endocrinology

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cen.12513PMID 24889858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrated Whole-Body PET/MRI With 18F-FDG, 18F-FDOPA, and 18F-FDA in Paragangliomas in Comparison With PET/CT: NIH First Clinical Experience With a Single-Injection, Dual-Modality Imaging Protocol

  2014cited by this paper
• Diagnostic accuracy of 68Ga-DOTANOC PET/CT imaging in pheochromocytoma

  2014cited by this paper
• Multimodality imaging findings of pheochromocytoma with associated clinical and biochemical features in 53 patients with histologically confirmed tumors.

  2013cited by this paper
• Comparison of Five Parathyroid Scintigraphic Protocols

  2013cited by this paper
• Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma

  2012cited by this paper
• Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma

  2012cited by this paper
• In Vitro and In Vivo Characterization of Three 68Ga- and 111In-Labeled Peptides for Cholecystokinin Receptor Imaging

  2012cited by this paper
• Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer

  2012cited by this paper
• Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening

  2012cited by this paper
• Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123I

  2012cited by this paper
• EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma

  2012cited by this paper
• Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

  2012cited by this paper
• Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.

  2012cited by this paper
• PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET

  2012cited by this paper
• Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas

  2012cited by this paper
• Management of medullary thyroid carcinoma and MEN2 syndromes in childhood

  2011cited by this paper
• Unilateral Subtotal Adrenalectomy for Pheochromocytoma in Multiple Endocrine Neoplasia Type 2 Patients: A Feasible Surgical Strategy

  2011cited by this paper
• Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

  2011cited by this paper
• Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma

  2010cited by this paper
• Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cited by this paper
• Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.

  2010cited by this paper
• Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome

  2009cited by this paper
• 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

  2009cited by this paper
• Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

  2009cited by this paper
• The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT

  2009cited by this paper
• Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A.

  2008cited by this paper
• 18F-Dihydroxyphenylalanine PET in Patients with Biochemical Evidence of Medullary Thyroid Cancer: Relation to Tumor Differentiation

  2008cited by this paper
• Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma

  2007cited by this paper
• Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.

  2006cited by this paper
• Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.

  2005cited by this paper
• Pheochromocytoma: an imaging chameleon.

  2004cited by this paper
• Surgical management of hereditary pheochromocytoma.

  2004cited by this paper
• Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout

  2002cited by this paper
• Biochemical diagnosis of pheochromocytoma: which test is best?

  2002cited by this paper
• Immunohistochemical detection of somatostatin receptor types 1–5 in medullary carcinoma of the thyroid

  2001cited by this paper
• 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

  2001cited by this paper
• Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.

  2000cited by this paper
• Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa.

  1999cited by this paper
• Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.

  1998cited by this paper
• Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.

  1997cited by this paper
• Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.

  1997cited by this paper
• Management of Pheochromocytomas in Patients with Multiple Endocrine Neoplasia Type 2 Syndromes

  1993cited by this paper
• Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.

  1991cited by this paper
• CLINICS 2012;67(S1):69-75 DOI:10.6061/clinics/2012(Sup01)13 REVIEW

  year unknowncited by this paper

• Rare RET Variants in a Patient With MEN2A and Multiple Follicular-Derived Thyroid Tumors: A Case Report and Review of the Literature.

  2026cites this paper
• Management and Long-Term Monitoring of a Young Patient with Pheochromocytoma and RET Mutation: A Case Report

  2025cites this paper
• Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.

  2025cites this paper
• Pheochromocytoma in MEN2.

  2025cites this paper
• Neoplasia endocrina múltiple

  2024cites this paper
• IN SILICO ANALYSIS OF IDENTIFIED MOST FREQUENT MUTATIONS IN EXON 10, CODON 618 OF THE HUMAN RET GENE

  2024cites this paper
• Prominent corneal nerves in pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B

  2023cites this paper
• Young woman with Multiple Endocrine Neoplasia 2B (MEN 2B) Diagnosed by PET-CT-A Case Report

  2022cites this paper
• Multiple endocrine neoplasia type 2 (MEN2).

  2021cites this paper
• A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis

  2021influential citation
• Advances in Diagnosis and Management of Primary Hyperparathyroidism due to Multiple Endocrine Neoplasia (MEN) Type 2 Syndrome

  2020cites this paper
• Anesthesia Management for Pediatric Patient With Multiple Endocrine Neoplasia Type 2B: A Case Report.

  2020cites this paper
• Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing

  2020cites this paper
• Flush after unilateral adrenalectomy

  2020cites this paper
• Emission

  2020cites this paper
• Medullary Thyroid Carcinoma: An Update on Imaging

  2019cites this paper
• Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes

  2018influential citation
• Visual Diagnosis: Exophytic Lesions on Tongue and Oral Mucosa

  2018cites this paper
• Imaging and Screening of Hereditary Cancer Syndromes.

  2017influential citation
• A comprehensive review on MEN2B.

  2017cites this paper
• Syncronous medullar thyroid cancer and primary hyperparathyroidism on a female within the sixth decade of life with positive family history for type 2A MEN syndrome

  2016cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.

  2016cites this paper
• Pheochromocytoma-paraganglioma: Biochemical and genetic diagnosis.

  2016cites this paper
• Recurrent hyperparathyroidism due to proliferation of autotransplanted parathyroid tissue in a multiple endocrine neoplasia type 2A patient

  2016cites this paper
• Parathyroid Adenoma, Gastric Adenocarcinoma, and Intraabdominal Schwannoma in One Patient

  2016cites this paper
• Surgical Management of Parathyroid and Adrenal Glands in Inherited Medullary Thyroid Carcinoma

  2016cites this paper
• Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies.

  2016cites this paper
• Outcome of adrenal sparing surgery in heritable pheochromocytoma: the example of multiple endocrine neoplasia type 2

  2015cites this paper
• Endocrine neoplasms in familial syndromes of hyperparathyroidism.

  2015cites this paper
• Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.

  2015cites this paper
• A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.

  2015cites this paper
• Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.

  2015cites this paper
• A Critical Approach to Clinical Biochemistry of Chromogranin A.

  2015cites this paper
• Perioperative Management of Pheochromocytoma.

  2002cites this paper